Diabete di tipo 1 con anticorpi negativi: quando è importante cercare un'altra diagnosi

A 15-year-old girl presented with diabetes mellitus without ketoacidosis, initially treated as type 1 diabetes (T1DM). Despite a family history of diabetes, the patient showed reduced insulin requirements (0.3 U/kg/day) and tested negative for autoantibodies associated with T1DM. Following ISPAD guidelines, genetic testing was performed, revealing a heterozygous mutation in the HNF4α gene, associated with MODY 1 (Maturity-Onset Diabetes of the Young). The patient maintained good glycemic control with insulin therapy, but the case raises questions about the timing and approach to transitioning to sulfonylureas, the first-line treatment for MODY 1, which could potentially improve glycemic control and the quality of life.

Authors

Institutions

Publication Details

Journal
Medico e Bambino pagine elettroniche
Published
2024-09-26
DOI
https://doi.org/10.53126/mebxxviio148
Primary Topic
Diabetes and associated disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Diabete di tipo 1 con anticorpi negativi: quando è importante cercare un'altra diagnosi

Giacomo Tantari, Giuseppe d’Annunzio, Marta Bassi, Nicola Minuto et al.
Medico e Bambino pagine elettroniche
Diabetes and associated disorders
article

Diabete di tipo 1 con anticorpi negativi: quando è importante cercare un'altra diagnosi

Giacomo Tantari, Giuseppe d’Annunzio, Marta Bassi, Nicola Minuto, Chiara Gulisano, Camilla Marazzi
article en

Abstract

A 15-year-old girl presented with diabetes mellitus without ketoacidosis, initially treated as type 1 diabetes (T1DM). Despite a family history of diabetes, the patient showed reduced insulin requirements (0.3 U/kg/day) and tested negative for autoantibodies associated with T1DM. Following ISPAD guidelines, genetic testing was performed, revealing a heterozygous mutation in the HNF4α gene, associated with MODY 1 (Maturity-Onset Diabetes of the Young). The patient maintained good glycemic control with insulin therapy, but the case raises questions about the timing and approach to transitioning to sulfonylureas, the first-line treatment for MODY 1, which could potentially improve glycemic control and the quality of life.

Medico e Bambino pagine elettronicheVol. 27(8)
Istituto Giannina Gaslini (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Good health and well-being
Openalex Percentile: Top 82%
Diabetes and associated disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.